Samples obtained from all protocols were analyzed by Western blots with 4-12% SDS-PAGE (Invitrogen, NP0322BOX). Western blot assays were performed as described previously (Sherwood et al., 2010 (link)). The following primary antibodies were used for immunoblotting: anti-LDH-A (1/1000, Santa Cruz, sc- 27230), anti-LDH-B (1/500, Novus Biologicals, NB100-79987), and anti-LDH (1/1000, Santa Cruz, sc-133123). Antibodies were characterized in detail before being used for research (see the Supplemental Material). The blots were also probed with antibodies against cell-specific marker proteins: anti-GFAP (glial marker, 1/1000, Santa Cruz, sc-9065) and anti-SYP (presynaptic neuronal marker, 1/1000, Abcam, ab14692). For detection of antibodies, appropriate peroxidase-conjugated secondary antibodies were used in conjunction with enhanced chemiluminescence (Amersham Pharmacia Biosciences) to obtain images saved on film. The signals were quantitatively evaluated with Scion Image software. Equal protein loading was confirmed with anti-β-actin antibody (1/1000, Santa Cruz Biotechnology, sc-1616). Protein bands were scanned using an EPSON Perfection 4870 Photo scanner and quantitatively analyzed by Scion Image software.